Journal of Clinical Urology
Share

Journal of Clinical Urology

Published in Association with British Association of Urological Surgeons
Formerly British Journal of Medical and Surgical Urology

Editor-in-Chief
Ian Pearce BMedSci, BMBS, FRCS (Urol) Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK

Other Titles in:
Urology

eISSN: 20514166 | ISSN: 20514158 | Current volume: 10 | Current issue: 4

The Journal of Clinical Urology, formerly British Journal of Medical and Surgical Urology, is a clinically orientated journal of urology and is an official publication of the British Association of Urological Surgeons. To reflect recent major changes in the field of urology, in particular the increasing importance of non-surgical management, considerable input is expected from medical urology as well as from the more surgically focused aspects of the specialty.

The journal covers the whole scope of urology in five sections to align it with the BAUS specialist sections: oncology; endourology; female neurological and urodynamic urology; andrology and genito-urethral surgery; and academic/basic science. It publishes high-quality original audit and research, commissioned reviews, comment articles and relevant case reports, with the overall aim of being readable, educational and clinically relevant to everyday urological practice. The audience is primarily consultant and trainee urologists, but in the longer term it will attract specialists in fields allied to urology including uro-radiology, uro-oncology, genito-urinary medicine and nursing.

This journal is a member of the Committee on Publication Ethics (COPE)

The Journal of Clinical Urology (JCU), formerly British Journal of Medical and Surgical Urology, is a clinically orientated journal of urology and is an official publication of the British Association of Urological Surgeons. To reflect recent major changes in the field of urology, in particular the increasing importance of non-surgical management, considerable input is expected from medical urology as well as from the more surgically focused aspects of the specialty.

The journal covers the whole scope of urology in five sections to align it with the BAUS specialist sections: oncology; endourology; female neurological and urodynamic urology; andrology and genito-urethral surgery; and academic/basic science. It publishes high-quality original audit and research, commissioned reviews, comment articles and relevant case reports, with the overall aim of being readable, educational and clinically relevant to everyday urological practice. The audience is primarily consultant and trainee urologists, but in the longer term it will attract specialists in fields allied to urology including uro-radiology, uro-oncology, genito-urinary medicine and nursing.

Founding Editor
Justin Vale MBBS, MS, FRCS (Urol) Imperial College London, London, UK
Associate Editors
Erik Mayer BSc (Hons), PhD, FRCS (Urol) Imperial College London, London, UK
Sri Sriprasad MBBS, DNB, MSc (Urol), FRCS (Urol), FEBU Darent Valley Hospital, Dartford, UK
Andrew Thorpe MCh, FRCS(Ed), FRCS (Urol) Freeman Hospital, Newcastle, UK
Social Media Editor
Vaibhav Modgil FRCS (Urol) Fiona Stanley Hospital, Perth, Australia
Editorial Board
Anuruddha Abeygunasekera MBBS, MS, FRCS (Edin), FRCS (Eng) Colombo South Teaching Hospital, Dehiwala, Sri Lanka
Maarten Albersen MD, PhD University Hospitals Leuven, Leuven, Belgium
Chris Blick DPhil, FRCS (Urol) Royal Berkshire Foundation Trust, Reading, UK
Christian Brown BSc, MD, FRCS (Urol) Kings and Guys NHS Foundations Trusts, London, UK
Jose Dominguez LMS, MD, FRCS (Urol) Instituto Valenciano de Oncologia, Valencia, Spain
Garrett Durkan MD FRCSI (Urol) University Hospital Galway, Galway, Ireland
Mikkel Fode MD, PhD, FECSM Roskilde Hospital, Roskilde, Denmark
Vincent Gnanapragasam BMedSci, MA, PhD, FRCS, FRCSEd(Urol) University of Cambridge, Cambridge, UK
Jonathan Glass MBBS, FRCS (Urol) Guys & St Thomas' Hospital Trust, London, UK
Tamsin Greenwell MBChB, MD, FRCS (Urol) University College London Hospital, London, UK
Rebecca Hamm MBChB (Hons), FRCS (Urol), MD Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK
Chris Harding MA, MB, Bchir, MD, FRCS (Urol) Freeman Hospital & Newcastle University, Newcastle, UK
Dickon Hayne MBBS, MD, FRCS (Eng), FRCS (Urol, FRACS (Urol) University of Western Australia, Perth, Australia
Paul Jones FRCS (Urol), LLM Morriston Hospital, Swansea, UK
Kathleen Kobashi MD, FACS Virginia Mason Medical Center, Seattle, USA
Carlos Llorente MD, PhD Hospital Universitario Fundacion Alcorcon, Madrid, Spain
John McCabe MBChB, FRCS (Urol) Whiston Hospital, Liverpool, UK
Kim L Moretti MBBS, MAICD, FRACS (Urol) The Queen Elizabeth Hospital, Adelaide, Australia
Asif Muneer BSc, MBChB, FRCS, MD, FRCS (Urol) University College London Hospital, London, UK
Katia Noyes PhD, MPH University of Rochester Medical Center, Rochester, USA
Teng Aik Ong MBBS, MS, FEBU, FRCS (Urol) University of Malaya Medical Centre, Kuala Lumpur, Malaysia
Robert Pickard MD, FRCS (Urol) Newcastle Univeristy, Newcastle, UK
Justine Royle MBChB, MD, FRCS (Urol) Aberdeen Royal Infirmary, Aberdeen, UK
Nicholas Rukin MBChB, MD, FRCS (Urol) Royal Wolverhampton Hospital NHS Trust, Wolverhampton, UK
Andrew Sinclair MBBS, BSc (Hons), FRCS (Urol) Stepping Hill Hospital, Stockport, UK
Tim Terry MBBS, LRCP , MRCS, FRCS, MS Leicester General Hospital, Leicester, UK
Pedro Vendeira MD, PhD, FECSM (Urol) Clínica do Dragão - Saúde Atlântica, Porto, Portugal
  • CCC
  • DeepDyve
  • Dutch-KB
  • EBSCO: Leadership & Management Source
  • Portico
  • Pro-Quest-RSP
  • SCOPUS
  • SwetsWise All Titles
  • Manuscript Submission Guidelines: Journal of Clinical Urology

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/URO to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Journal of Clinical Urology will be reviewed.

    There are no fees payable to submit or publish in this journal.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. What do we publish?
      1.1 Aims & Scope
      1.2 Article types
      1.3 Writing your paper
    2. Editorial policies
      2.1 Peer review policy
      2.2 Authorship
      2.3 Acknowledgements
      2.4 Funding
      2.5 Declaration of conflicting interests
      2.6 Research ethics and patient consent
      2.7 Clinical trials
      2.8 Reporting guidelines
      2.9 Data
      2.10 Guarantor
      2.11 Contributorship
      2.12 Statistical analysis
    3. Publishing policies
      3.1 Publication ethics
      3.2 Contributor's publishing agreement
      3.3 Open access and author archiving
    4. Preparing your manuscript
      4.1 Formatting
      4.2 Artwork, figures and other graphics
      4.3 Supplementary material
      4.4 Reference style
      4.5 English language editing services
    5. Submitting your manuscript
      5.1 ORCID
      5.2 Information required for completing your submission
      5.3 Publication of Twitter handles
      5.4 Permissions
    6. On acceptance and publication
      6.1 SAGE Production
      6.2 Online First publication
      6.3 Access to your published article
      6.4 Promoting your article
    7. Further information

    1. What do we publish?

    1.1 Aims & Scope

    Before submitting your manuscript to Journal of Clinical Urology, please ensure you have read the Aims & Scope.

    1.2 Article Types

    Journal of Clinical Urology accepts the following kinds of articles:

    Original Research Article
    Including: Case Series; Case-Control Studies; Cohort Studies; Cross-Sectional Studies and Randomised Control Trials.

    Papers should be as concise as possible and generally not exceed 2,500 words (excluding references). Each paper should be formatted as follows:

    Title page: The title should be concise with no abbreviations. Please provide the surname, initials, department, institution, city and country of each author, and the name, email address, full mailing address, telephone number and fax number of the corresponding author to whom proofs should be sent. 
    Abstract: The second page of the manuscript must contain only the abstract, which should be of no more than 200 words and must be clearly written and comprehensive to readers before they have to read the paper.

    The abstract should be sub-divided into:
    Objective: a short statement of the aims, not a long paragraph of background information 
    Subjects/patients (or materials) and methods
    Results: Please avoid long lists of detailed values, but state the main findings
    Conclusion: Please state whether the aims have been met. References should be avoided, but if essential, they must be cited in full. Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.

    Immediately after the abstract, please provide a list of 3-6 keywords, using English spelling and avoiding general and plural terms and multiple concepts (avoid, for example, `and’, `of’). Be sparing with abbreviations: only abbreviations firmly established in the field are eligible. These keywords will be used for indexing purposes.

    Any manuscripts submitted without a structured abstract will be returned to the author immediately without peer review, thus delaying the evaluation process.

    Abbreviations: Define abbreviations that are not standard in this field at their first occurrence in the article. Ensure consistency of abbreviations throughout the article. (Please also see section 4.1 below)

    Introduction: (max 300 words) The introduction should assume that the reader is knowledgeable in the field and aim to be concise.
    State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

    Experimental/Materials and Methods: Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.

    Results

    Discussion: (max 800 words). This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is sometimes appropriate. Avoid extensive citations and discussion of published literature. 

    Conclusions: The main conclusions of the study should be presented

    References: Please see section 4.4 below

    ‘Case which changed my practice’(Max 700 words)
    Papers for this section of the journal should comply with the following:

    Articles should not exceed 700 words (excluding references). They should include a brief summary of the case followed by a discussion putting the learning point in context, and a clear statement of what you have learned from the case. Illustrations (X-rays, clinical photos) are encouraged, but must contain nothing which could identify the patient. Consent to use any such materials must be obtained from the patient prior to publication and authors will be asked to confirm that they have done so on the copyright transfer form. There should be no more than 7 relevant references.

    Case reports (max 500 words)
    Articles should comply with the following: 

    Case reports should not exceed 500 words (excluding references). They should include a brief summary of the case and then discussion about the interesting aspects of the case. Illustrations (X-rays, clinical photos) are encouraged, but must contain nothing which could identify the patient. Consent to use any such materials must be obtained from the patient prior to publication and authors will be asked to confirm that they have done so on the copyright transfer form. There should be no more than 5 relevant references. It is important to bear in mind that a case will be published only if it has an interesting clinical message. Just because a condition is unusual does not necessarily make it of interest, and conversely a common condition can present or behave in an unusual way making it an informative case study. 

    Reviews/comments

    Including: critical reviews, literature reviews and meta-analysis

    These articles are generally commissioned by the Editor and the length agreed with the prospective author. In all other aspects a review should comply with the general guidelines in terms of nomenclature, title page, figures and references. If you have suggestions for a review please contact the editorial office (uro@sagepub.com).

    Role of the Expert Witness:

    These articles should not exceed 1,500 words.

    Points of Technique/Other:

    These articles should not exceed 1,000 words.

    For all article types please note:

    Nomenclature and units: Please supply, as a separate list, the definitions of field-specific terms used in your article. Follow internationally accepted rules and conventions: use the international system of units (SI). If other quantities are mentioned, give their equivalent in SI (please also see section 4.1 below)

    Declarations
    Please note that all manuscripts should be accompanied by a separate document entitled ‘Declarations’.

    Please read the Declarations guideline for authors available here: http://journals.sagepub.com/pb-assets/cmscontent/URO/declaration_policy_document-jcu.pdf  carefully before submitting your Declarations document.

    This should be submitted under the file designation ‘Declarations’. This must include each of the below headings with the corresponding information. Please note that manuscripts which do not include these Declarations will be returned. These headings will be published at the end of every accepted manuscript, where one of these headings is not applicable please indicate as such under the heading.  

    DECLARATIONS
    1. Conflicting interests 
    2. Funding 
    3. Informed consent
    4. Ethical approval
    5. Guarantor 
    6. Contributorship
    7. Acknowledgements

    Example of a completed Declarations document:

    DECLARATIONS
    Conflicting interests: MS is an employee of XXX. BF has received grants from XXX. 
    Funding: This work was supported by the Medical Research Council [grant number XXX]
    Informed consent: Written informed consent was obtained from the patient(s) for their anonymized information to be published in this article.
    Ethical approval: The ethics committee of  XXXX approved this study (REC number: XXXX)
    Guarantor: BF
    Contributorship: BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript
    Acknowledgements: We would like to thank XXX XXXX for his assistance and guidance in this research.
    Please read the following information carefully for additional information regarding these declarations. 

    Levels of Evidence

    Please supply a Level of Evidence according to the Oxford Centre for Evidence-based Medicine Levels of Evidence (March 2009) and the end of the abstract of all submissions. If a level of evidence is not applicable please include a statement declaring this this at the end of the abstract.

    1.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    1.3.1 Make your article discoverable

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

    Back to top

    2. Editorial policies

    2.1 Peer review policy

    Journal of Clinical Urology operates a single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. Each manuscript is reviewed by at least two referees. Referees will be encouraged to provide substantive, constructive reviews that provide suggestions for improving the work and distinguish between mandatory and non-mandatory recommendations. All manuscripts are reviewed as rapidly as possible, and an editorial decision from the Editor-in-Chief, based on the reviewers’ recommendations and his own analysis of the article, is generally reached within 4-6 weeks of submission.

    When submitting your article in SAGE track, you will be required to select the main topic of your manuscript. It is important that you choose a category from the drop-down menu. This will ensure that your article is dealt with and reviewed as quickly as possible.

    As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

      • The reviewer should have no prior knowledge of your submission
      • The reviewer should not have recently collaborated with any of the authors
      • Reviewer nominees from the same institution as any of the authors are not permitted

    Please note that the Editor(s) are not obliged to invite any recommended/opposed reviewers to assess your manuscript. As part of this process you will also be asked to explain to the journal Editor why each person is recommended or opposed.

    Journal of Clinical Urology is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for Journal of Clinical Urology  can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

    2.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

      1. Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
      2. Drafted the article or revised it critically for important intellectual content,
      3. Approved the version to be published,
      4. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Please supply any personal acknowledgements as part of your declarations document (see section 1.2) to facilitate anonymous peer review.

    2.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

    2.4 Funding

    Journal of Clinical Urology requires all authors to acknowledge their funding in a consistent fashion within their declarations document (see section 1.2).  Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    2.5 Declaration of conflicting interests

    It is the policy of Journal of Clinical Urology to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included as part of your declarations document (see section 1.2). If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    2.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section and as part of the declarations document that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text and as part of your declarations document (see section 1.2). A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.7 Clinical trials

    Journal of Clinical Urology conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract and within the separate declarations document.

    2.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    2.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Journal of Clinical Urology requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at URO@sagepub.com

    2.10 Guarantor

    The Guarantor is the person willing to take full responsibility for the article, including for the accuracy and appropriateness of the reference list. This will often be the most senior member of the research group and is commonly also the author for correspondence. Please state this person’s name as initials within your declarations document (see section 1.2).

    2.11 Contributorship

    For multi-authored papers this statement should outline what each party contributed to the authorship of the paper within the declarations document (see section 1.2). Authors should be identified by their initials. An example is shown below.

    BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript.

    2.12 Statistical analysis

    Where statistical analyses have been carried out please ensure that the methodology has been accurately described. In comparative studies, power calculations are usually required. In research papers, requiring complex statistics, the advice of an expert statistician should be sought at the design/implementation stage of the study.

    Back to top

    3. Publishing Policies

    3.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    3.1.1 Plagiarism

    Journal of Clinical Urology and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    3.1.2 Prior publication

    If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    3.2 Contributor's publishing agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.

    3.3 Open access and author archiving

    Journal of Clinical Urology offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    Back to top

    4. Preparing your manuscript for submission

    4.1 Formatting

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    For detailed advice please refer to the guidelines in Baron, DN (1988). Units, symbols and abbreviations, 4th edn. (Obtainable from The Royal Society of Medicine, 1 Wimpole Street, London W1M 8AE, UK). Note that the SI system of units is preferred. Because of the multidisciplinary nature of the readership and to avoid confusion, the number of abbreviations in the text should be kept to a minimum. Standard abbreviations acceptable without definition are limited to the following:

    CNS (central nervous system); CSF (cerebrospinal fluid); DNA (deoxyribonucleic acid); HLA (human leukocyte antigen; MRI (magnetic resonance imaging); CT (computerized tomography); MS (multiple sclerosis); RNA (ribonucleic acid). Nonstandard definitions must be defined in full at their first usage in the abstract and again at their first use in the text.

    4.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.  

    Figures supplied in colour will appear in colour online and in the print issue. There is no charge for reproducing figures in colour in the printed version.

    Tables
    Tables should be submitted in Word, typed on separate pages. Tables should be numbered consecutively with Arabic numerals, and cited as such in the manuscript.

    The preferred placing of tables in the main text should be indicated. Tables should include a brief descriptive title and be self-explanatory. Footnotes to tables indicated by lower-case superscript letters are acceptable, but they should not include extensive experimental details.

    4.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.

    4.4 Reference style

    Journal of Clinical Urology adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver EndNote output file.

    4.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    5. Submitting your manuscript

    Journal of Clinical Urology is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/uro to login and submit your article online.

    When making a submission, the following separate, unpaginated documents should be uploaded. Please do not submit one combined document. The separate files will be combined into a pdf in the online system.

    1. Title page (title, names of authors, affiliations, keywords, corresponding author)
    2. Main document (includes structured abstract, main text, acknowledgements, references)
    3. Tables (each as a separateWord document)
    4. Figure legends (Word document)
    5. Figures (as separatetiff, jpg or eps files)
    6. Any supplementary files
    7. Declarations (please see section 1.2)

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    5.1 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.

    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.

    5.2 Information required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    5.3 Publication of Twittter handles

    Journal of Clinical Urology has its own Twitter account @JCUrology.

    As a way of encouraging ongoing discussion within the field, Journal of Clinical Urology authors are offered the option of providing their Twitter handle to be published alongside their name and email address within their article. This way, Journal of Clinical Urology readers who have questions or thoughts regarding your paper can tweet you directly. Providing a Twitter handle for publication is entirely optional, if you are not comfortable with Journal of Clinical Urology promoting your article along with your personal Twitter handle then please do not supply it.

    By providing your personal twitter handle you agree to let Journal of Clinical Urology and SAGE Publications use it in any posts related to your journal article. You may also be contacted by other Twitter users. Journal of Clinical Urology and SAGE Publications will have no control over you or your tweets at any time. If you would like guidance on how to promote your article yourself on Twitter or other Social Media channels please visit http://www.uk.sagepub.com/journalgateway/files/using_social_media_to_promote.doc.

    For further information please also see the GMC guidance on the use of social media by doctors: http://www.baus.org.uk/Resources/BAUS/Documents/PDF%20Documents/News/Doctors__use_of_social_media.pdf.pdf 

    To include your Twitter handle within your article please provide this within the SAGE Track Submission form when prompted and on the separate title page in the format outlined below (please refrain from adding this to the manuscript itself to facilitate anonymous peer review). 

    Joe Bloggs, Department of Urology, Urology University Hospital, JCU Town, JC1 345, UK.
    Email: JoeBloggs@email.com
    Twitter: @drjoebloggs 

    5.4 Permissions

    Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.

    Back to top

    6. On acceptance and publication

    6.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

    6.2 Online First publication

    Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.

    6.3 Access to your published article

    SAGE provides authors with online access to their final article.

    6.4 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos

    Back to top

    7. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Clinical Urology editorial office as follows:

    uro@sagepub.com

    Individual Subscription, E-access


    Individual Subscription, Print Only


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Individual, Single Print Issue


    Institutional, Single Print Issue